Comments Regarding Proposed Rule for Nonprescription Drug Product With an Additional Condition for Nonprescription Use Share page: Docket Number: FDA–2021–N–0862 Download Document Issues: OTC Medicines Rx-to-OTC Switch Related Posts Comments Comments Regarding FDA Annual Reportable Labeling Changes for New Drug Applications and Abbreviated New Drug Applications for Nonprescription Drug Products May 13, 2024 Press Releases and Statements CHPA Applauds Vermont for Passing Sun Safety Bill Empowering Students to Better Protect their Skin May 8, 2024 Press Releases and Statements Tennessee Expands Access to OTC Cold & Allergy Medications Containing PSE May 7, 2024